XTend Medical (XMDC) Penetrates $118 Million European Telemedicine Market

SUN VALLEY, CA, Jul 22 (MARKET WIRE) --
XTend Medical Corporation (PINKSHEETS: XMDC), a company that delivers
cutting-edge telemedicine solutions to the healthcare industry, announced
today the company will begin a telemedicine program in Europe to track
the remote monitoring of diabetic patients in early August. According to
Frost and Sullivan the European market is expected to hit $236 Million by
2014.

The company released the following statement: "Our presence here in the
U.S. has attracted many companies from Europe that are interested on our
telehealth programs. While many companies offer a similar solution, the
fact that XTend's solution was chosen over these is critical in the fact
that our solutions are widely accepted as being the easiest to implement
and maintain. This is a major accomplishment as our marketing efforts in
educating the medical community as to the ease with which our system can
be integrated into their practice has proven once again to stand above our
competitor's solutions. By having a presence in Europe, this will assist
the company as we grow our brand globally over the next three years and
on. We'll release further information regarding our European program as
the results are monitored through the University that has asked us to
maintain their privacy for now," stated Mr. Paul D. Lisenby, CEO of XTend
Medical.

For any healthcare agency or physician group that would like to find out
more about how XTend can assist in your management of diabetic patients,
please visit the company website at www.xtendmedical.com or email us at
info@xtendmedical.com

About XTend Medical: XTend Medical Corporation markets and sells
telehealth and telemedicine solutions for monitoring and caring for
patients with chronic disease conditions. XTend has developed a complete
Remote Diabetic Patient Monitoring System that is currently being used by
physicians and other healthcare agencies throughout the U.S. Through
their alliances, XTend offers pharmacy services, diabetic supplies, and
telemedicine products that increase patient care yet reduce costs
associated with servicing those patients. For more information, please
visit their website at www.xtendmedical.com.

Safe Harbor

This press release contains or may contain forward-looking statements such
as statements regarding the Company's growth and profitability, growth
strategy, liquidity and access to public markets, operating expense
reduction, and trends in the industry in which the Company operates. The
forward-looking statements contained in this press release are also
subject to other risks and uncertainties, including those more fully
described in the Company's filings with the Securities and Exchange
Commission. The Company assumes no obligation to update these
forward-looking statements to reflect actual results, changes in risks,
uncertainties or assumptions underlying or affecting such statements, or
for prospective events that may have a retroactive effect.

Company Contact:
FutureTechIR for XTend Medical Corporation
Investor Relations
(817) 812-2105

Copyright 2008, Market Wire, All rights reserved.

-0-